Cost-effectiveness analysis of Human Papillomavirus (HPV) vaccination in the Netherlands: recent publication reinforces favorable cost-effectiveness despite misleading conclusion

Vaccine. 2010 Jan 22;28(4):873-4. doi: 10.1016/j.vaccine.2009.10.109. Epub 2009 Nov 5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Netherlands / epidemiology
  • Papillomavirus Infections / economics*
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / economics*
  • Papillomavirus Vaccines / immunology*
  • Vaccination / economics*

Substances

  • Papillomavirus Vaccines